These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 17357253
1. Preventing cervical cancer. Parsons J. Aust Fam Physician; 2007 Mar; 36(3):101. PubMed ID: 17357253 [Abstract] [Full Text] [Related]
2. HPV-vaccine and screening programs: the new era of global prevention. Mariani L. J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438 [No Abstract] [Full Text] [Related]
3. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer. Ault K, Reisinger K. Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242 [Abstract] [Full Text] [Related]
6. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine. Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911 [Abstract] [Full Text] [Related]
7. Human papillomavirus vaccines: an update for gynecologists. Ault KA. Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145 [Abstract] [Full Text] [Related]
8. HPV and cervical cancer in the 2007 report. WHO/ICO Information Centre on HPV and Cervical Cancer. Vaccine; 2007 Nov 01; 25 Suppl 3():C1-230. PubMed ID: 18068032 [No Abstract] [Full Text] [Related]
10. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]. Schneider A, Schwarz TF, Hammerschmidt T, Siebert U. Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869 [Abstract] [Full Text] [Related]
11. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE, Unger ER, Saraiya M. J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
13. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D. Gynecol Oncol; 2008 Sep 01; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [Abstract] [Full Text] [Related]
14. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines. Hampl M. Minerva Med; 2007 Apr 01; 98(2):121-30. PubMed ID: 17519854 [Abstract] [Full Text] [Related]
16. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme]. de Kok IM, Habbema JD, Mourits MJ, Coebergh JW, van Leeuwen FE. Ned Tijdschr Geneeskd; 2008 Nov 29; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259 [No Abstract] [Full Text] [Related]
17. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme]. van der Noordaa J, Houweling H. Ned Tijdschr Geneeskd; 2008 Oct 18; 152(42):2267-9. PubMed ID: 19009873 [Abstract] [Full Text] [Related]
18. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Khan K, Curtis CR, Ekwueme DU, Stokley S, Walker C, Roland K, Benard V, Saraiya M. Cancer; 2008 Nov 15; 113(10 Suppl):3004-12. PubMed ID: 18980296 [Abstract] [Full Text] [Related]
19. [Human papilloma virus and cervical cancer]. Berumen-Campos J. Gac Med Mex; 2006 Nov 15; 142 Suppl 2():51-9. PubMed ID: 19031679 [Abstract] [Full Text] [Related]
20. Vaccine against papilloma virus: a review of the clinical studies. Gabutti G. J Prev Med Hyg; 2009 Jun 15; 50(2):79-89. PubMed ID: 20099437 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]